Nikki Lodha

Nikki Lodha is a financial market writer covering Indian equities, corporate developments, and macro-driven market trends. She focuses on simplifying complex market moves into clear, actionable insights for investors and traders.
Follow:
843 Articles

Trump’s 200% US Generic Drug Tariff Plan Puts Indian Pharma Stocks in Focus; Who Faces the Biggest Risk?

Sun Pharma, Cipla, Dr Reddy's Laboratories, Lupin, Aurobindo Pharma and Zydus Lifesciences…

Nikki Lodha

Stocks to Watch Today: Maruti, Bandhan Bank, Adani, Indian Hotels in Focus; 20 Q1 Results Due

Key Takeaways GIFT Nifty signals a weak start; Sensex and Nifty closed…

Nikki Lodha

London Stock Exchange Launches LSE 24 For 5 PM-7:50 AM Trading

London Stock Exchange Group (LSEG) said Tuesday it will launch LSE 24,…

Nikki Lodha

SBI Funds Management Lists Below GMP but Stock Jumps 8.6%; Emkay Sees ₹750 Target

Key Takeaways SBI Funds Management listed at Rs 613.30 on NSE (up…

Nikki Lodha

ITC Sets Up a Crucial Week: ₹14.50 Dividend Vote Ahead of July 31 Earnings

Shareholders ratify the FY26 payout this week even as a widening gap…

Nikki Lodha

CDSL Penalty, L&T Mega Orders and Q1 Earnings Set Up a High-Impact Trading Day

Markets Set the Stage Indian benchmarks ended lower on Monday, with the…

Nikki Lodha

No LTCG Tax Relief: Government Rejects Proposal as Collections Hit ₹2 Lakh Crore

KEY TAKEAWAYS Government has no proposal to scrap LTCG tax on equities,…

Nikki Lodha

Auto Ancillary Stocks Back in Focus After Goldman Sachs’ Fresh Ratings

Key Takeaways Goldman Sachs initiated coverage on four Indian auto ancillary stocks…

Nikki Lodha

BHEL Fires Up Again as Profit Returns After Eight Years

Key Takeaways BHEL swung to a consolidated net profit of Rs 376.71…

Nikki Lodha
Go to Top
Join our WhatsApp channel
Subscribe to our YouTube channel